These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 11173476

  • 1. Crystallization and preliminary studies of the DNA-binding runt domain of AML1.
    Bäckström S, Huang SH, Wolf-Watz M, Xie XQ, Härd T, Grundström T, Sauer UH.
    Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):269-71. PubMed ID: 11173476
    [Abstract] [Full Text] [Related]

  • 2. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
    Bäckström S, Wolf-Watz M, Grundström C, Härd T, Grundström T, Sauer UH.
    J Mol Biol; 2002 Sep 13; 322(2):259-72. PubMed ID: 12217689
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
    Kurokawa M, Hirai H.
    Cancer Sci; 2003 Oct 13; 94(10):841-6. PubMed ID: 14556655
    [Abstract] [Full Text] [Related]

  • 10. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.
    Michaud J, Wu F, Osato M, Cottles GM, Yanagida M, Asou N, Shigesada K, Ito Y, Benson KF, Raskind WH, Rossier C, Antonarakis SE, Israels S, McNicol A, Weiss H, Horwitz M, Scott HS.
    Blood; 2002 Feb 15; 99(4):1364-72. PubMed ID: 11830488
    [Abstract] [Full Text] [Related]

  • 11. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.
    Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T.
    Blood; 2004 Mar 15; 103(6):2316-24. PubMed ID: 14615365
    [Abstract] [Full Text] [Related]

  • 12. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C.
    Leukemia; 2003 Jan 15; 17(1):9-16. PubMed ID: 12529654
    [Abstract] [Full Text] [Related]

  • 13. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
    Zent C, Rowley JD, Nucifora G.
    Leukemia; 1997 Apr 15; 11 Suppl 3():273-8. PubMed ID: 9209363
    [Abstract] [Full Text] [Related]

  • 14. Oncogenic potential of the RUNX gene family: 'overview'.
    Ito Y.
    Oncogene; 2004 May 24; 23(24):4198-208. PubMed ID: 15156173
    [Abstract] [Full Text] [Related]

  • 15. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
    Nakao M, Horiike S, Fukushima-Nakase Y, Nishimura M, Fujita Y, Taniwaki M, Okuda T.
    Br J Haematol; 2004 Jun 24; 125(6):709-19. PubMed ID: 15180860
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F, Pisegna S, Diverio D.
    Haematologica; 1997 Jun 24; 82(3):364-70. PubMed ID: 9234595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.